SEC Form 4 · accession 0001209191-16-096450
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard E Rominger
Director
Period of report
Feb 4, 2016
Accepted (ET)
Feb 8, 2016 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2016 | M | 3,836 | $0.078 | A | 3,836 | D | |
| Common StockF1 | holding | — | — | — | 99,522 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.078 | Feb 4, 2016 | M | 3,836 | D | — | Aug 14, 2016 | Common Stock | 3,836 | 0 | D |
Explanation of responses
- F1The Richard and Mary Rominger Community Trust.
- F2The option vested with respect to 1/4th of the total shares subject to the option on the first anniversary of the vesting commencement date of August 15, 2007, and 1/48th of the total shares subject to the option monthly thereafter for 36 months.